Japan’s Nikkei share gauge slid for a third-straight session on Monday as concerns about an upcoming domestic election and ...

With major U.S. equity indexes sitting just below record highs, Nomura's Charlie McElligott has some advice for investors: Now is the time to buy downside protection for their portfolios. In his ...

Stocks fell on Wall Street as the Trump administration stepped up pressure on trading partners to make deals before punishing ...

Nomura raises Nifty target to 26,140 for March 2026, highlights 17 high-conviction stock picks Nomura has raised its Nifty 50 target to 26,140 for March 2026, citing India's macroeconomic ...

Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!

One stock to keep an eye on is Nomura (NMR). NMR is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 7.69 right now.

One stock to keep an eye on is Nomura (NMR). NMR is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. The stock is trading with P/E ratio of 7.69 right now. For comparison, ...

Nomura sees 5% upside, expects Nifty at 23,784 by December: 3 key predictions to watch Nomura projects Nifty could rise 5% by Dec 2025, sector focus noted. Watch key stock shifts.

Nomura (NMR) is a stock many investors are watching right now. NMR is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock is trading with P/E ratio of 9.77 right now.

Nomura's current P/E ratio of 11.09 and forward P/E of 10.91 suggest the stock is trading at relatively modest valuations, which could be attractive to value investors despite the short-term ...

On Friday, Jefferies adjusted its stance on Nomura Research Institute Ltd. (4307:JP) (OTC: NRILY), downgrading the firm's stock from Buy to Hold while simultaneously increasing the price target to ...